• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类原发性肿瘤和自体转移瘤上的HLA I类基因表达:结直肠癌、胃癌和喉癌上HLA抗原选择性缺失的证明

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.

作者信息

López-Nevot M A, Esteban F, Ferrón A, Gutiérrez J, Oliva M R, Romero C, Huelin C, Ruiz-Cabello F, Garrido F

机构信息

Servicio de Análisis Clínicos, Hospital Virgen de las Nieves, Granada, Spain.

出版信息

Br J Cancer. 1989 Feb;59(2):221-6. doi: 10.1038/bjc.1989.45.

DOI:10.1038/bjc.1989.45
PMID:2649129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2246991/
Abstract

The expression of HLA class I antigens was studied in 99 primary tumour (colorectal, gastric and laryngeal carcinomas) and 57 autologous metastases using immunohistological techniques and monoclonal antibodies against class I monomorphic determinants, HLA-B isotypic determinants and HLA polymorphic determinants. Fourteen per cent of colorectal, 9.6% of gastric and 20% of laryngeal carcinomas completely lacked class I molecules. Selective losses of HLA-B antigens were also detected in 8.8, 3.4 and 5.8% of these tumours respectively. Taking into account complete and selective loss of HLA-B the average alteration in the class I molecules expression totalled 21%. The comparison of class I expression between primary tumours and autologous metastases showed differences in 24% of the patients. These differences consisted mainly in a decrease of class I expression by metastases. Nevertheless, four types of divergence were detected in laryngeal carcinomas, namely: +/-, +/+, -/+, -/-. In addition, a clear correlation between degree of differentiation and class I expression was observed in laryngeal tumours. Finally, when class I gene RFLPs were compared with DNA from 15 tumours and autologous normal mucosa or peripheral lymphocytes, no differences were detected between these samples.

摘要

利用免疫组织学技术以及针对I类单态决定簇、HLA - B同种型决定簇和HLA多态决定簇的单克隆抗体,对99例原发性肿瘤(结直肠癌、胃癌和喉癌)和57例自体转移瘤中的HLA I类抗原表达进行了研究。14%的结直肠癌、9.6%的胃癌和20%的喉癌完全缺乏I类分子。在这些肿瘤中,还分别检测到8.8%、3.4%和5.8%的肿瘤存在HLA - B抗原的选择性缺失。将HLA - B的完全缺失和选择性缺失考虑在内,I类分子表达的平均改变总计为21%。原发性肿瘤与自体转移瘤之间I类表达的比较显示,24%的患者存在差异。这些差异主要表现为转移瘤中I类表达的降低。然而,在喉癌中检测到四种差异类型,即:+/-、+/+、-/+、-/-。此外,在喉肿瘤中观察到分化程度与I类表达之间存在明显相关性。最后,当将I类基因RFLP与来自15个肿瘤及自体正常黏膜或外周淋巴细胞的DNA进行比较时,在这些样本之间未检测到差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/427f/2246991/68461ce09609/brjcancer00124-0082-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/427f/2246991/059546006c53/brjcancer00124-0082-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/427f/2246991/68461ce09609/brjcancer00124-0082-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/427f/2246991/059546006c53/brjcancer00124-0082-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/427f/2246991/68461ce09609/brjcancer00124-0082-b.jpg

相似文献

1
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.人类原发性肿瘤和自体转移瘤上的HLA I类基因表达:结直肠癌、胃癌和喉癌上HLA抗原选择性缺失的证明
Br J Cancer. 1989 Feb;59(2):221-6. doi: 10.1038/bjc.1989.45.
2
MHC class I and II antigens on gastric carcinomas and autologous mucosa.胃癌及自体黏膜上的MHC I类和II类抗原
J Immunogenet. 1989 Aug-Oct;16(4-5):413-23. doi: 10.1111/j.1744-313x.1989.tb00489.x.
3
Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.喉原发性和转移性鳞状细胞癌中的组织相容性抗原
Int J Cancer. 1989 Mar 15;43(3):436-42. doi: 10.1002/ijc.2910430316.
4
[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].[喉癌中肿瘤侵袭性的免疫调节。I. HLA I类抗原的遗传和分子研究]
Acta Otorrinolaringol Esp. 1990 Sep-Oct;41(5):297-303.
5
High frequency of altered HLA class I phenotypes in laryngeal carcinomas.喉癌中HLA I类表型改变的高频率。
Hum Immunol. 2000 May;61(5):499-506. doi: 10.1016/s0198-8859(00)00097-5.
6
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.多种机制在喉癌中产生HLA I类改变的表型:HLA单倍型缺失的高频率与6号染色体区域6p21杂合性缺失相关。
Cancer Immunol Immunother. 2002 Sep;51(7):389-96. doi: 10.1007/s00262-002-0296-0. Epub 2002 Jun 28.
7
MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.MUTYH相关息肉病癌常常失去HLA I类表达——这在DNA修复缺陷型结直肠癌中是常见现象。
J Pathol. 2009 Sep;219(1):69-76. doi: 10.1002/path.2569.
8
Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
Clin Exp Metastasis. 1989 Mar-Apr;7(2):213-26. doi: 10.1007/BF01787025.
9
[Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].[喉癌中肿瘤侵袭性的免疫调节。II. 与HLA ABC抗原表达缺失的临床病理相关性]
Acta Otorrinolaringol Esp. 1990 Nov-Dec;41(6):359-68.
10
Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.转移性乳腺癌和结肠癌中单一型和多态性HLA抗原的缺失
Br J Cancer. 1991 Nov;64(5):880-3. doi: 10.1038/bjc.1991.418.

引用本文的文献

1
Malignant features of minipig melanomas prior to spontaneous regression.小型猪黑色素瘤自发消退前的恶性特征。
Sci Rep. 2024 Apr 22;14(1):9240. doi: 10.1038/s41598-024-59741-w.
2
Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors.不同的突变过程塑造了主要和转移性肿瘤中 MHC Ⅰ类和Ⅱ类突变的选择。
Cell Rep. 2023 Aug 29;42(8):112965. doi: 10.1016/j.celrep.2023.112965. Epub 2023 Aug 21.
3
Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal Cancers.

本文引用的文献

1
MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.人血清细胞毒素的微滴分析法
Nature. 1964 Dec 5;204:998-1000. doi: 10.1038/204998b0.
2
Independent regulation of H-2K and H-2D gene expression in murine teratocarcinoma somatic cell hybrids.小鼠畸胎瘤体细胞杂种中H-2K和H-2D基因表达的独立调控
J Exp Med. 1980 Jun 1;151(6):1349-59. doi: 10.1084/jem.151.6.1349.
3
Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.主要组织相容性抗原:人类(HLA - A、- B、- C)和小鼠(H - 2K、H - 2D)I类分子。
晚期BRAF突变型结直肠癌中的肿瘤抗原性与预先存在的适应性免疫反应
Cancers (Basel). 2022 Aug 16;14(16):3951. doi: 10.3390/cancers14163951.
4
Assessment of Human Leukocyte Antigen Differences between Smokers with Reinke's Edema and Those with Laryngeal Cancer.伴有任克氏水肿的吸烟者与喉癌患者之间人类白细胞抗原差异的评估
Iran J Otorhinolaryngol. 2022 Mar;34(121):95-105. doi: 10.22038/IJORL.2022.52799.2797.
5
BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC.BET抑制剂JQ1可增强抗肿瘤免疫力,并与CRC中的PD-1阻断协同作用。
J Cancer. 2022 Mar 28;13(7):2126-2137. doi: 10.7150/jca.69375. eCollection 2022.
6
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.通过 MHC I 类抗原呈递丧失实现癌症免疫逃逸。
Front Immunol. 2021 Mar 9;12:636568. doi: 10.3389/fimmu.2021.636568. eCollection 2021.
7
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.结直肠癌中 HLA I 类分子的缺失:免疫逃逸和免疫治疗的意义。
Cell Mol Immunol. 2021 Mar;18(3):556-565. doi: 10.1038/s41423-021-00634-7. Epub 2021 Jan 20.
8
Cancer immune escape: MHC expression in primary tumours versus metastases.癌症免疫逃逸:原发性肿瘤与转移瘤中的 MHC 表达。
Immunology. 2019 Dec;158(4):255-266. doi: 10.1111/imm.13114. Epub 2019 Oct 1.
9
HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.乳腺癌中 HLA I 类分子的改变与染色体 6 和 15 杂合性丢失的高频率相关。
Immunogenetics. 2018 Nov;70(10):647-659. doi: 10.1007/s00251-018-1074-2. Epub 2018 Aug 25.
10
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).尼伏鲁单抗治疗复发性和转移性鼻咽癌的抗肿瘤活性:梅奥诊所第二阶段联盟(NCI-9742)的国际多中心研究。
J Clin Oncol. 2018 May 10;36(14):1412-1418. doi: 10.1200/JCO.2017.77.0388. Epub 2018 Mar 27.
Cell. 1981 May;24(2):287-99. doi: 10.1016/0092-8674(81)90318-4.
4
Clonal analysis of H-2 antigen expression by variants of a chemically induced murine tumor.化学诱导的小鼠肿瘤变体对H-2抗原表达的克隆分析。
Transplant Proc. 1981 Dec;13(4):1819-23.
5
Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens.源自同一患者不同黑色素瘤转移灶的细胞系表面抗原和糖蛋白表达的异质性。对肿瘤抗原研究的启示。
J Exp Med. 1981 Dec 1;154(6):1764-78. doi: 10.1084/jem.154.6.1764.
6
Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells.人类外周血单个核白细胞上的Ia抗原。I. HLA - DR抗原非T细胞的表达、生物合成及功能
J Exp Med. 1980 Aug 1;152(2 Pt 2):99s-113s.
7
MHC imbalance and metastatic spread in Lewis lung carcinoma clones.Lewis肺癌克隆中的MHC失衡与转移扩散
Int J Cancer. 1983 Jul 15;32(1):113-20. doi: 10.1002/ijc.2910320118.
8
The major histocompatibility complex in man.人类主要组织相容性复合体
Science. 1981 Sep 25;213(4515):1469-74. doi: 10.1126/science.6792704.
9
The detailed distribution of HLA-A, B, C antigens in normal human organs.HLA-A、B、C抗原在正常人体器官中的详细分布。
Transplantation. 1984 Sep;38(3):287-92. doi: 10.1097/00007890-198409000-00018.
10
Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.手术切除并培养的乳腺癌细胞中HLA和肿瘤相关抗原表达的异质性。
Cancer Res. 1983 Feb;43(2):660-8.